Wealthfront Advisers LLC 10x Genomics, Inc. Transaction History

Wealthfront Advisers LLC

  • $32.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 21, 2022
SELL
$135.05 - $182.59 $456,469 - $617,154
-3,380 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$145.58 - $192.14 $278,785 - $367,948
1,915 Added 130.72%
3,380 $492,000
Q2 2021

Aug 16, 2021
BUY
$134.22 - $202.37 $196,632 - $296,472
1,465 New
1,465 $287,000

Others Institutions Holding TXG

# of Institutions
291
Shares Held
94.7M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Wealthfront Advisers LLC Portfolio

Follow Wealthfront Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthfront Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthfront Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email